Edmund Griffin, MD

Dr. Griffin is an Assistant Professor of Clinical Psychiatry at Columbia University and an Attending Psychiatrist at NY Presbyterian Hospital. He received his BA in Biochemistry from Columbia University, his MD from Harvard Medical School, and PhD in Neurobiology from Harvard Medical School. During his Residency in Psychiatry at the Columbia-New York Presbyterian Medical Center, he was honored with the NIMH Outstanding Resident Award. Following residency training, Dr. Griffin completed a Postdoctoral Research Fellowship in the laboratory of Nobel Laureate Dr. Eric Kandel.

Dr. Griffin’s clinical and research interests focus on the substance abuse disorders. His neurobiological research investigates the specific molecular changes in the reward circuitry of the brain during the development and maintenance of addiction, with goal of developing novel and more effective therapeutic interventions. Dr. Griffin has won grants from both Federal and private institutions, including  the Leon Levy Foundation, the National Institute of Drug Addiction, and the Robert Wood Johnson Foundation. His findings on the molecular basis of drug addiction have been published in Science Advances and Science Translational Medicine.  His work has been featured in the New York Times, the LA Times, and Vice.